Fluorine-containing pyrazole compound and method for producing same
The production of fluorine-containing pyrazole compounds with a trifluoromethyl group at the 4th position and specific substituents at the 3rd and 5th positions is achieved through controlled reactions, resulting in compounds with improved biological activities and applications in electronic materials.
Patent Information
- Application Number
- JP2023517214
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-04-27
- Filing Date
- 2022-03-31
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2042-03-31
AI Technical Summary
Existing methods fail to efficiently produce fluorine-containing pyrazole compounds with a trifluoromethyl group at the 4th position and specific substituents at the 3rd and 5th positions of the pyrazole ring, lacking control over reactivity and reaction selectivity.
A method involving the reaction of fluoroisobutylene or fluoroisobutane derivatives with specific compounds in the presence of fluoride ion scavengers to form fluorine-containing pyrazole compounds, ensuring precise introduction of a trifluoromethyl group at the 4th position and substituents at the 3rd and 5th positions.
Enables the production of novel fluorine-containing pyrazole compounds with enhanced biological activities, such as bactericidal, herbicidal, and enzyme inhibitory effects, and potential applications in electronic materials.
Smart Images

Figure 0007595153000001 
Figure 0007595153000002 
Figure 0007595153000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a fluorine-containing pyrazole compound and a method for producing the same. [Background technology]
[0002] Fluorine-containing pyrazole compounds have been reported to have various biological activities. Among them, compounds that have a ring structure without a heteroatom as a substituent at the 1-position of the pyrazole ring and have substituents at the 3- and 5-positions of the pyrazole ring are considered to be promising for use in the pharmaceutical and agricultural chemical fields.
[0003] More specifically, Patent Document 1 reports that compounds having a 1-phenyl-pyrazole structure have fungicidal activity against rice blast, wheat rust, etc. Patent Document 2 reports that compounds having a 1-phenyl-pyrazole structure have herbicidal activity against Chenopodium album, Velvet, etc. Patent Document 3 reports that compounds having a 1-phenyl-pyrazole structure have inhibitory activity against matriptase 2, which is involved in the suppression of hepcidin.
[0004] Therefore, in hopes of improving useful activities such as biological activity, there has been interest in developing compounds having a substituent at the 1-position of the pyrazole ring consisting of a ring structure that does not have a heteroatom as a ring atom, substituents at the 3- and 5-positions of the pyrazole ring, and further a trifluoromethyl group at the 4-position of the pyrazole ring. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] International Publication No. 2014 / 051161 [Patent Document 2] International Publication No. 2015 / 089003 [Patent Document 3] International Publication No. 2020 / 072580 Summary of the Invention [Problem to be solved by the invention]
[0006] For a compound having a substituent consisting of a ring structure having no heteroatom as a ring atom at position 1 of the pyrazole ring and having substituents at positions 3 and 5, in order to further introduce a trifluoromethyl group at position 4, it is necessary to strictly control the reactivity and reaction selectivity of the substrate, and no examples of the production of such a compound have been reported so far. For this reason, further development of a fluorine-containing pyrazole compound having a substituent consisting of a ring structure having no heteroatom as a ring atom at position 1, having substituents at positions 3 and 5, and further having a trifluoromethyl group at position 4 has been desired.
[0007] Therefore, the present inventors discovered that a substituent consisting of a specific ring structure having no heteroatom as a ring atom at position 1 of a pyrazole ring, a trifluoromethyl group at position 4, and specific substituents at positions 3 and 5 can be introduced by reacting specific raw materials, and have completed the present invention. That is, the present invention provides a novel fluorine-containing pyrazole compound which has not been known before and which has a substituent consisting of a specific ring structure having no heteroatom as a ring atom at position 1, a trifluoromethyl group at position 4, and specific substituents at positions 3 and 5, and a production method which enables the fluorine-containing pyrazole compound to be simply produced. [Means for solving the problem]
[0008] The gist and configuration of the present invention are as follows. [1] A fluorine-containing pyrazole compound represented by the following general formula (1): [ka] (In the above general formula (1), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent, or a fused ring not containing a heteroatom as a ring atom.) [2] The fluorine-containing pyrazole compound according to the above [1], wherein the ring Z has 6, 10, 14, 18 or 22 π electrons. [3] A method for producing a fluorinated pyrazole compound, comprising a step of reacting a fluoroisobutylene derivative represented by the following general formula (2) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorinated pyrazole compound represented by the following general formula (1). [ka] (In the above general formulas (1) to (3), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent or a fused ring not containing a heteroatom as a ring atom. [4] A method for producing a fluorinated pyrazole compound, comprising a step of reacting a fluoroisobutane derivative represented by the following general formula (4) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorinated pyrazole compound represented by the following general formula (1). [ka] (In the above general formulas (1), (3) and (4), R represents a hydrocarbon group having 1 to 12 carbon atoms; X is a halogen atom, -OA 1 , -SO m A 1 (m is an integer from 0 to 3), or -NA 1 A 2 represents A 1 , A 2 each independently represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, Ring Z represents a substituted phenyl group or a fused ring that does not contain a heteroatom as a ring atom. [5] The method for producing a fluorine-containing pyrazole compound according to the above [3] or [4], wherein the step of obtaining the fluorine-containing pyrazole compound is carried out in the presence of a fluoride ion scavenger. [6] The method for producing a fluorine-containing pyrazole compound according to any one of the above [3] to [5], wherein the ring Z has 6, 10, 14, 18 or 22 π electrons. Effect of the Invention
[0009] The present invention provides a novel fluorine-containing pyrazole compound having a substituent at the 1-position consisting of a specific ring structure having no heteroatom as a ring atom, a trifluoromethyl group at the 4-position, and specific substituents at the 3- and 5-positions, and a production method by which the fluorine-containing pyrazole compound can be simply produced. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] (Fluorine-containing pyrazole compound) The fluorine-containing pyrazole compound of the present invention is represented by the following general formula (1). [ka] (In the above general formula (1), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent, or a fused ring not containing a heteroatom as a ring atom.)
[0011] The fluorine-containing pyrazole compound of the present invention has a phenyl group having a substituent on the 1-position of the pyrazole ring, or a fused ring (e.g., polycyclic aromatic hydrocarbon) Z group not containing heteroatoms such as N (nitrogen), S (sulfur), or O (oxygen) as ring atoms constituting the ring structure, and specific substituents (-OR, -CF3, -F) on the 3-, 4-, and 5-positions of the pyrazole ring, so that it can have excellent effects in terms of structural expandability. In particular, it can be expected to have desired biological activity (e.g., hormone or enzyme inhibitory activity, fungicidal activity, insecticidal activity, herbicidal activity). The fused ring (e.g., polycyclic aromatic hydrocarbon) Z not containing heteroatoms as ring atoms located on the 1-position of the pyrazole ring may or may not have a substituent. The ring Z can impart desired properties to the fluorine-containing pyrazole compound depending on the ring size, the number of ring atoms, the number of π electrons constituting the ring Z, and the number, type, and presence or absence of substituents. In addition, since the substituents on the 3-position and 5-position of the pyrazole ring are different groups (-OR and -F), these groups can be eliminated or reacted to easily derivatize into an asymmetric structure, and the compound can be expected to be used as an intermediate. More specifically, a derivative can be obtained by modifying -OR by reacting a fluorine-containing pyrazole compound under acidic conditions. Also, a derivative can be obtained by modifying -F by reacting a fluorine-containing pyrazole compound under basic conditions. The fluorine-containing pyrazole compound of one embodiment is useful in the field of electronic materials such as organic semiconductors and liquid crystals.
[0012] R is not particularly limited as long as it is a hydrocarbon group having 1 to 12 carbon atoms and composed of carbon atoms and hydrogen atoms, and examples thereof include a chain hydrocarbon group, an aromatic hydrocarbon group, and an alicyclic hydrocarbon group. The chain hydrocarbon group is not particularly limited as long as it has a total carbon number of 1 to 12, and may be a branched chain hydrocarbon group or an unbranched chain hydrocarbon group. The aromatic hydrocarbon group is not particularly limited as long as it has a total carbon number of 5 to 12, and may be an aromatic hydrocarbon group having a substituent or an aromatic hydrocarbon group having no substituent. The aromatic hydrocarbon group may have a condensed polycyclic structure. The alicyclic hydrocarbon group is not particularly limited as long as it has a total carbon number of 3 to 12, and may be an alicyclic hydrocarbon group having a substituent or an alicyclic hydrocarbon group having no substituent. The alicyclic hydrocarbon group may have a bridged ring structure.
[0013] Examples of the chain hydrocarbon group include alkyl groups such as a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, an i-butyl group, a sec-butyl group, a t-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, an undecyl group, and a dodecyl group; alkenyl groups such as ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, and dodecenyl groups; Examples of the alkynyl group include an ethynyl group, a propynyl group, a butynyl group, a pentynyl group, a hexynyl group, a heptynyl group, an octynyl group, a nonynyl group, a decynyl group, an undecynyl group, and a dodecynyl group.
[0014] Examples of the aromatic hydrocarbon group include a phenyl group and a naphthyl group.
[0015] The alicyclic hydrocarbon group may be a saturated or unsaturated cyclic hydrocarbon group, and examples of the cyclic hydrocarbon group include a cyclopropyl group, a cyclobutyl group, a cyclohexyl group, a cyclopentyl group, an adamantyl group, and a norbornyl group.
[0016] R is preferably an alkyl group having 1 to 10 carbon atoms. When R is an alkyl group having 1 to 10 carbon atoms, the fluoroisobutylene derivative of general formula (2) and the fluoroisobutane derivative of general formula (4), which are raw materials for the fluorine-containing pyrazole compound, can be easily prepared.
[0017] Ring Z may be a phenyl group having a substituent of a monocyclic structure, or a group consisting of a condensed ring structure containing no heteroatoms as ring atoms.
[0018] Typically, the number of π electrons constituting ring Z is 4n+2 (n is a positive integer), but the number of π electrons is preferably 6, 10, 14, 18 or 22. The number of π electrons constituting ring Z is more preferably 6 or 10. When ring Z has the above-mentioned structure, the polarity and planarity of the fluorine-containing pyrazole compound are controlled, improving the dynamics and imparting more effective biological activity.
[0019] More specifically, examples of the group consisting of ring Z include a phenyl group having a substituent, a naphthyl group, a chloronaphthyl group, a bromonaphthyl group, a methoxynaphthyl group, a dihydroacenaphthyl group, an anthracenyl group, a phenanthryl group, a phenalenyl group, a pyrenyl group, a triphenylenyl group, a tetracenyl group, a chrysenyl group, a benz[a]anthracenyl group, a benzo[c]phenanthryl group, a perylenyl group, a pentacenyl group, a benzo[a]pyrenyl group, a benzo[e]pyrenyl group, a benzo[a]tetracenyl group, a corannulenyl group, a pentacenyl group, a picenyl group, a dibenzo[a,j]anthracenyl group, etc. Among these groups, the group consisting of ring Z is preferably a phenyl group having a substituent, a naphthyl group, a naphthyl group having a substituent, a dihydroacenaphthyl group, or a phenanthryl group. In addition, when the ring Z is a condensed ring that does not contain a heteroatom as a ring atom, the ring atom in the group consisting of the ring Z may or may not be further bonded with a substituent. When the ring Z is a condensed ring that does not contain a heteroatom as a ring atom, the substituent of the ring Z may or may not have a heteroatom, and examples of the substituent include halogen atoms such as Cl and Br, alkyl groups, alkoxy groups such as OMe, and halogenated alkyl groups such as CF3. In addition, when the ring Z is a phenyl group having a substituent, the number of the substituents is not particularly limited as long as it is 1 to 5, and examples of the substituent include halogen atoms such as F, Cl, Br, and I, alkyl groups such as methyl groups, halogenated alkyl groups such as CF3, nitro groups, alkoxy groups such as OMe, halogenated alkoxy groups such as OCF3, and sulfonyl groups.
[0020] (Method of producing fluorine-containing pyrazole compound) A method for producing a fluorine-containing pyrazole compound according to one embodiment includes the steps of: (a) reacting a fluoroisobutylene derivative represented by the following general formula (2) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorine-containing pyrazole compound represented by the following general formula (1): has. [ka] (In the above general formulas (1) to (3), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent or a fused ring not containing a heteroatom as a ring atom. The step (a) of obtaining a fluorine-containing pyrazole compound is preferably carried out in the presence of a fluoride ion scavenger, that is, the fluoroisobutylene derivative represented by the general formula (2) is reacted with the compound represented by the general formula (3) or a salt thereof in the presence of a fluoride ion scavenger. The fluoride ion trapping agent is not particularly limited as long as it has a function of trapping fluorine ions, and examples of the fluoride ion trapping agent include lithium, sodium, magnesium, potassium, calcium, tetramethylammonium, trifluoroacetic acid, heptafluorobutyric acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, trifluoromethanesulfonic acid, nonafluorobutanesulfonic acid, bis(trifluoromethanesulfonyl)imide, bis(nonafluorobutanesulfonyl)imide, N,N-hexafluoropropane-1,3-disulfonylimide, tetraphenylboric acid, tetrakis[3,5-bis(trifluoromethyl)phenyl]boric acid, and tetrakis(pentafluorophenyl)borate. The cation derived from the fluoride ion trapping agent traps the fluorine ion liberated from the fluoroisobutylene derivative represented by general formula (2) during the reaction, and precipitates it as a salt with low solubility in an organic solvent, thereby promoting the reaction, and the fluorine-containing pyrazole compound represented by the above general formula (1) can be obtained in high yield.
[0021] In the above general formulas (1) and (3), the number of π electrons constituting the ring Z is preferably 6, 10, 14, 18, or 22. Furthermore, in the above general formulas (1) and (2), R preferably represents an alkyl group having 1 to 10 carbon atoms.
[0022] The above reaction (a) between the fluoroisobutylene derivative represented by general formula (2) and the compound represented by general formula (3) is represented by the following reaction formula (A). [ka]
[0023] In the above reaction formula (A), the compound of general formula (3) may be in the form of a salt. When it is in the form of a salt, at least one of the amino moiety (-NH2) and the imino moiety (=NH) constituting the amidino group of the compound of general formula (3) is cationized (-NH3 + ) and (=NH2 + ) and forms a salt with the counter ion. The counter ion is not particularly limited as long as it is a monovalent anion, and for example, F - , Cl - , Br - , I - Examples of the halide ions include:
[0024] In one embodiment of the method for producing a fluorine-containing pyrazole compound, for example, the reaction (a) can be carried out in one step in the presence of a hydrogen halide scavenger. Therefore, the fluorine-containing pyrazole compound of the general formula (1) can be obtained simply. In the reaction (a), a cyclic pyrazole structure is formed between the fluoroisobutylene derivative and the amidino group of the compound of the general formula (3). The 1-position of the pyrazole structure is occupied by a group derived from the ring structure Z of the compound of the general formula (3). In addition, the 3-position, 4-position, and 5-position of the pyrazole structure are occupied by -OR, CF3, and F derived from the fluoroisobutylene derivative, respectively.
[0025] The hydrogen halide scavenger is a substance having a function of scavenging hydrogen fluoride (HF) formed from a hydrogen atom derived from an amidino group in the compound of general formula (3) in the above reaction formula (A) and a fluorine atom derived from a fluoroisobutylene derivative of general formula (2). Examples of hydrogen halide scavengers that can be used include sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium fluoride, potassium fluoride, and organic nitrogen derivatives such as pyridine, triethylamine, diisopropylethylamine, diazabicyclononene, diazabicycloundecene, methyltriazabicyclodecene, diazabicyclooctane, and phosphazene bases.
[0026] The reaction temperature during the above reaction (a) is preferably 0 to 100° C., more preferably 5 to 50° C., and even more preferably 10 to 20° C. The reaction time during the above reaction (a) is preferably 1 to 48 hours, more preferably 2 to 36 hours, and even more preferably 4 to 24 hours.
[0027] Examples of the solvent used in the reaction (a) above include aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide, and sulfolane, and two-phase solvents of a protic polar solvent such as water and a non-aqueous solvent such as dichloromethane, toluene, and diethyl ether. In addition, examples of the catalyst used in the reaction (a) above include quaternary ammonium halides such as benzyltriethylammonium chloride, quaternary phosphonium halides, and crown ethers.
[0028] In another embodiment, a method for producing a fluorine-containing pyrazole compound includes the steps of: (b) reacting a fluoroisobutane derivative represented by the following general formula (4) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorine-containing pyrazole compound represented by the following general formula (1): has. [ka] (In the above general formulas (1), (3) and (4), R represents a hydrocarbon group having 1 to 12 carbon atoms; X is a halogen atom, -OA 1 , -SO m A 1 (m is an integer from 0 to 3), or -NA 1 A 2 represents A 1 , A 2 each independently represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, Ring Z represents a substituted phenyl group or a fused ring that does not contain a heteroatom as a ring atom. Preferably, the step (b) of obtaining a fluorine-containing pyrazole compound is carried out in the presence of a fluoride ion scavenger. It is preferable to react the fluoroisobutane derivative represented by the general formula (4) with the compound represented by the general formula (3) or a salt thereof in the presence of a fluoride ion scavenger. The fluoride ion trapping agent is not particularly limited as long as it has a function of trapping fluorine ions, and examples of the fluoride ion trapping agent include lithium, sodium, magnesium, potassium, calcium, tetramethylammonium, trifluoroacetic acid, heptafluorobutyric acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, trifluoromethanesulfonic acid, nonafluorobutanesulfonic acid, bis(trifluoromethanesulfonyl)imide, bis(nonafluorobutanesulfonyl)imide, N,N-hexafluoropropane-1,3-disulfonylimide, tetraphenylboric acid, tetrakis[3,5-bis(trifluoromethyl)phenyl]boric acid, and tetrakis(pentafluorophenyl)borate. The cation derived from the fluoride ion trapping agent traps the fluorine ion liberated from the fluoroisobutane derivative represented by the general formula (4) during the reaction, and precipitates it as a salt with low solubility in an organic solvent, thereby promoting the reaction, and the fluorine-containing pyrazole compound represented by the general formula (1) can be obtained in high yield.
[0029] In the above general formulas (1) and (3), the number of π electrons constituting the ring Z is preferably 6, 10, 14, 18, or 22. Furthermore, in the above general formulas (1) and (4), R preferably represents an alkyl group having 1 to 10 carbon atoms.
[0030] The above reaction (b) of the fluoroisobutane derivative represented by general formula (4) with the compound represented by general formula (3) is represented by the following reaction formula (B). [ka]
[0031] In the above reaction formula (B), the compound of general formula (3) may be in the form of a salt. When it is in the form of a salt, at least one of the amino moiety (-NH2) and the imino moiety (=NH) constituting the amidino group of the compound of general formula (3) is cationized (-NH3 + ) and (=NH2 + ) and forms a salt with the counter ion. The counter ion is not particularly limited as long as it is a monovalent anion, and for example, F - , Cl - , Br - , I - Examples of the halide ions include:
[0032] X is a halogen atom, and examples of such an atom include F, Cl, Br, and I. X is -OA. 1 , -SO m A 1 (m is an integer from 0 to 3) 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. X is -NA 1 A 2 A included in 1 , A 2 Each independently represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms. 1 , A 2When represents a hydrocarbon group having 1 to 10 carbon atoms, for example, the above R can be a hydrocarbon group having 1 to 10 carbon atoms.
[0033] In another embodiment of the method for producing a fluorine-containing pyrazole compound, for example, the reaction (B) can be carried out in one step. Therefore, the fluorine-containing pyrazole compound of the general formula (1) can be obtained simply. In the reaction (b) above, a cyclic pyrazole structure is formed between the fluoroisobutane derivative (4) and the amidino group of the compound of the general formula (3). A group derived from the ring structure Z of the compound of the general formula (3) is located at the 1-position of the pyrazole structure. In addition, -OR, CF3, and F derived from the fluoroisobutane derivative are located at the 3-position, 4-position, and 5-position of the pyrazole structure, respectively.
[0034] The reaction temperature in the above reaction (b) is preferably 0 to 100° C., more preferably 5 to 50° C., and even more preferably 10 to 20° C. The reaction time in the above reaction (b) is preferably 1 to 48 hours, more preferably 2 to 36 hours, and even more preferably 4 to 24 hours. In the above reaction (b), the same hydrogen halide scavenger as in the above reaction (a) can be used.
[0035] Examples of the solvent used in the reaction (b) above include aprotic polar solvents such as tetrahydrofuran, monoglyme, diglyme, triglyme, tetraglyme, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide, and sulfolane, and two-phase solvents of a protic polar solvent such as water and a non-aqueous solvent such as dichloromethane, toluene, and diethyl ether. In addition, examples of the catalyst used in the reaction (b) above include quaternary ammonium halides such as benzyltriethylammonium chloride, quaternary phosphonium halides, and crown ethers.
[0036] Although the embodiments of the present invention have been described above, the present invention is not limited to the above-described embodiments, and includes all aspects encompassed by the concept of the present invention and the scope of the claims, and can be modified in various ways within the scope of the present invention. EXAMPLES
[0037] Next, in order to further clarify the effects of the present invention, examples will be described, but the present invention is not limited to these examples.
[0038] Example 1 Preparation of 5-fluoro-3-methoxy-1-(9-phenanthryl)-4-trifluoromethylpyrazole 0.3g (1.0mmol) of 9-phenanthrylhydrazine hydrochloride and 0.3g (1.4mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-trifluoromethyl-1-propene were dissolved in 10ml of THF (tetrahydrofuran), and 0.6g (3.9mmol) of 1,8-diazabicyclo[5.4.0]undec-7-ene (hereinafter sometimes referred to as "DBU") was added dropwise. After stirring at room temperature for about 64.3 hours, the reaction solution was purified by column purification, and 0.3g (0.9mmol) of 5-fluoro-3-methoxy-1-(9-phenanthryl)-4-trifluoromethylpyrazole represented by the following formula (C) was isolated. The isolation yield of 5-fluoro-3-methoxy-1-(9-phenanthryl)-4-trifluoromethylpyrazole was 2.5%.
[0039] [ka]
[0040] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 360.4 ([M] + ) 1H-NMR (300MHz, CDCl3) δppm:8.77(d,8.3Hz,1H),8.74(d,J=8.3Hz,1H),7.95(dd,J=7.3,0.6Hz,1H),7.86(s,1H),7.74-7.80(m,2H),7.66-7.70(m,3H),4.02(s,3H)
[0041] Example 2 Preparation of 5-fluoro-3-methoxy-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-trifluoromethylpyrazole 0.5g (2.1mmol) of 2,6-dichloro-4-(trifluoromethyl)phenylhydrazine was dissolved in 12ml of acetonitrile, 2.1g (6.1mmol) of sodium tetraphenylborate, 0.5g (2.4mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 0.9g (5.9mmol) of DBU were added, and the mixture was stirred at room temperature for 88 hours. The reaction solution was purified by column chromatography to obtain a trace amount of crude product of 0.3g (0.9mmol) of 5-fluoro-3-methoxy-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-trifluoromethylpyrazole represented by the following formula (D).
[0042] [ka]
[0043] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 396.7 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-59.5(d,3F), -108.4(dd,1F)
[0044] Example 3 Preparation of 5-fluoro-3-methoxy-1-(9-phenanthryl)-4-trifluoromethylpyrazole using 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane instead of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene in Example 1 0.3g (1.0mmol) of 9-phenanthrylhydrazine hydrochloride and 0.3g (1.4mmol) of 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane were dissolved in 10ml of THF (tetrahydrofuran), and 0.6g (3.9mmol) of 1,8-diazabicyclo[5.4.0]undec-7-ene was added dropwise. After stirring at room temperature for about 64.3 hours, the analytical results of the obtained compound were the same as those of the product of Example 1.
[0045] Example 4 Preparation of 5-fluoro-3-methoxy-1-[2,6-dichloro-4-(trifluoromethyl)phenyl])-4-trifluoromethylpyrazole using 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane instead of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene in Example 2 0.5g (2.1mmol) of 2,6-dichloro-4-(trifluoromethyl)phenylhydrazine was dissolved in 12ml of acetonitrile, 2.1g (6.1mmol) of sodium tetraphenylborate, 0.6g (2.4mmol) of 1,1,1,3,3-pentafluoro-3-methoxy-2-(trifluoromethyl)-propane and 0.9g (5.9mmol) of DBU were added, and the mixture was stirred at room temperature for 88 hours. The analytical results of the compound obtained were the same as those of the product in Example 2.
[0046] Example 5 Preparation of 5-fluoro-3-methoxy-1-(1-naphthyl)-4-trifluoromethylpyrazole 0.5g (2.6mmol) of 1-naphthylhydrazine hydrochloride was dissolved in 26ml of tetrahydrofuran, 0.6g (2.8mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6g (10.5mmol) of DBU were added, and the mixture was stirred at room temperature for 64.3 hours. The reaction solution was then purified with a column to obtain 0.005g of a crude product of 5-fluoro-3-methoxy-1-(1-naphthyl)-4-trifluoromethylpyrazole represented by the following formula (E).
[0047] [ka]
[0048] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 311.6 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.07(d,J=10.1Hz,3F),-120.47(q,J=10.1Hz,1F)
[0049] Example 6 Preparation of 5-fluoro-3-methoxy-1-(4-bromo-1-naphthyl)-4-trifluoromethylpyrazole 0.5 g (1.8 mmol) of (4-bromo-1-naphthyl)hydrazine hydrochloride was dissolved in 18 ml of tetrahydrofuran, 0.4 g (1.9 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.1 g (7.2 mmol) of DBU were added, and the mixture was stirred at room temperature for 87.5 hours. The reaction solution was then purified using a column to obtain 0.01 g of a crude product of 5-fluoro-3-methoxy-1-(4-bromo-1-naphthyl)-4-trifluoromethylpyrazole represented by the following formula (F).
[0050] [ka]
[0051] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 389.3 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.15(d,J=10.1Hz,3F),-120.16(q,J=10.1Hz,1F)
[0052] Example 7 Preparation of 1-(4-chloro-1-naphthyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.2 mmol) of (4-chloro-1-naphthyl)hydrazine hydrochloride was dissolved in 22 ml of tetrahydrofuran, 0.5 g (2.4 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.3 g (8.5 mmol) of DBU were added, and the mixture was stirred at room temperature for 88.9 hours. The reaction solution was then purified using a column to obtain 0.01 g of a crude product of 1-(4-chloro-1-naphthyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (G).
[0053] [ka]
[0054] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 345.3 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.15(d,J=10.1Hz,3F),-120.20(q,J=10.1Hz,1F)
[0055] Example 8 Preparation of 1-(1,2-dihydroacenaphthylene-5-yl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.2 mmol) of (1,2-dihydroacenaphthylen-5-yl)hydrazine hydrochloride was dissolved in 23 ml of tetrahydrofuran, 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.4 g (9.2 mmol) of DBU were added, and the mixture was stirred at room temperature for 70.3 hours. The reaction solution was then purified using a column to obtain 0.03 g of a crude product of 1-(1,2-dihydroacenaphthylen-5-yl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (H).
[0056] [ka]
[0057] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 337.6 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.00(d,J=10.1Hz,3F),-120.82(q,J=10.1Hz,1F)
[0058] Example 9 Preparation of 5-fluoro-3-methoxy-1-(2-naphthyl)-4-trifluoromethylpyrazole 0.5 g (2.6 mmol) of 2-naphthylhydrazine hydrochloride was dissolved in 26 ml of tetrahydrofuran, and 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6 g (10.5 mmol) of DBU were added and stirred at room temperature for 66.4 hours. The reaction solution was then purified with a column to obtain 0.01 g of a crude product of 5-fluoro-3-methoxy-1-(2-naphthyl)-4-trifluoromethylpyrazole represented by the following formula (I).
[0059] [ka]
[0060] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 311.5 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.25(d,J=10.1Hz,3F),-120.43(q,J=10.1Hz,1F)
[0061] Example 10 Preparation of 5-fluoro-3-methoxy-1-(6-methoxynaphthalen-2-yl)-4-trifluoromethylpyrazole 0.5g (1.9mmol) of (6-methoxynaphthalen-2-yl)hydrazine hydrochloride was dissolved in 19ml of tetrahydrofuran, 0.5g (2.4mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.2g (7.9mmol) of DBU were added, and the mixture was stirred at room temperature for 71.3 hours. The reaction solution was purified by column chromatography to obtain 0.01g (0.02mmol) of 5-fluoro-3-methoxy-1-(6-methoxynaphthalen-2-yl)-4-trifluoromethylpyrazole represented by the following formula (J). The yield of 5-fluoro-3-methoxy-1-(6-methoxynaphthalen-2-yl)-4-trifluoromethylpyrazole was 1.2%.
[0062] [ka]
[0063] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 341.4 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.17(d,J=10.1Hz,3F),-120.92(q,J=10.1Hz,1F)
[0064] Example 11 Preparation of 1-(6-bromonaphthalen-2-yl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (1.8 mmol) of (6-bromonaphthalen-2-yl)hydrazine hydrochloride was dissolved in 18 ml of tetrahydrofuran, 0.4 g (1.9 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.1 g (7.2 mmol) of DBU were added, and the mixture was stirred at room temperature for 64.4 hours. The reaction solution was then purified using a column to obtain 0.01 g of a crude product of 1-(6-bromonaphthalen-2-yl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (K).
[0065] [ka]
[0066] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 389.4 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.32(d,J=10.1Hz,3F),-120.13(q,J=10.1Hz,1F)
[0067] Example 12 Preparation of 5-fluoro-1-(4-fluorophenyl)-3-methoxy-4-trifluoromethylpyrazole 0.5g (3.1mmol) of 4-fluorophenylhydrazine hydrochloride was dissolved in 19.2ml of tetrahydrofuran, 3.0g (9.2mmol) of potassium bis(trifluoromethanesulfonyl)imide, 0.8g (3.8mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene, and 2.9g (9.3mmol) of the phosphazene base P1-t-Bu-tris(tetramethylene) were added, and the mixture was stirred at room temperature for 69.5 hours. The reaction solution was purified by a column to obtain a crude product of 5-fluoro-1-(4-fluorophenyl)-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (L).
[0068] [ka]
[0069] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 279.5 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.31(d,J=10.1Hz,3F),-114.55--114.47(m,1H),-121.14(q,J=10.1Hz,1F)
[0070] Example 13 Preparation of 1-(4-chlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.8 g (2.8 mmol) of p-chlorophenylhydrazine hydrochloride was dissolved in 28 ml of acetonitrile, 0.7 g (3.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.9 g (14.6 mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 72.4 hours. The reaction solution was then purified with a column to obtain 0.02 g of a crude product of 1-(4-chlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (M).
[0071] [ka]
[0072] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 295.4 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.40(d,J=10.1Hz,3F),-120.32(q,J=10.1Hz,1F)
[0073] Example 14 Preparation of 1-(2,4-dichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.8 g (2.4 mmol) of 2,4-dichlorophenylhydrazine hydrochloride was dissolved in 23 ml of acetonitrile, 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6 g (12.3 mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 63.3 hours. The reaction solution was then purified with a column to obtain 0.02 g of a crude product of 1-(2,4-dichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (N).
[0074] [ka]
[0075] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 329.2 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.41(d,J=10.1Hz,3F),-118.40(q,J=10.1Hz,1F)
[0076] Example 15 Preparation of 5-fluoro-3-methoxy-1-(4-methoxyphenyl)-4-trifluoromethylpyrazole 0.5g (2.9mmol) of 4-methoxyphenylhydrazine hydrochloride was dissolved in 29ml of acetonitrile, 0.7g (3.3mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.0g (15.2mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 89.5 hours. The reaction solution was purified by column chromatography to obtain 0.1g (0.3mmol) of 5-fluoro-3-methoxy-1-(4-methoxyphenyl)-4-trifluoromethylpyrazole represented by the following formula (O). The yield of 5-fluoro-3-methoxy-1-(4-methoxyphenyl)-4-trifluoromethylpyrazole was 11.9%.
[0077] [ka]
[0078] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 391.2 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.17(d,J=10.1Hz,3F),-121.85(q,J=10.1Hz,1F)
[0079] (Example 16) Preparation of 5-fluoro-3-methoxy-1-(4-nitrophenyl)-4-trifluoromethylpyrazole 0.5 g (2.7 mmol) of 4-nitrophenylhydrazine hydrochloride was dissolved in 26 ml of acetonitrile, 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.8 g (14.1 mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 65.8 hours. The reaction solution was then purified using a column to obtain a crude product of 5-fluoro-3-methoxy-1-(4-nitrophenyl)-4-trifluoromethylpyrazole represented by the following formula (P).
[0080] [ka]
[0081] The analytical results of the obtained target substance are as follows: 19 F-NMR (400MHz, CDCl3) δppm:-58.72(d,J=11.6Hz,3F),-117.87(q,J=10.1Hz,1F)
[0082] (Example 17) Preparation of 1-(4-bromophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5g (2.2mmol) of 4-bromophenylhydrazine hydrochloride was dissolved in 22ml of acetonitrile, 0.5g (2.4mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.5g (12.0mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 62.8 hours. The reaction solution was then purified with a column to obtain 0.05g of a crude product of 1-(4-bromophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (Q).
[0083] [ka]
[0084] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 338.9 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.42(d,J=10.1Hz,3F),-120.17(q,J=10.1Hz,1F)
[0085] (Example 18) Preparation of 1-[4-(trifluoromethoxy)phenyl]-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.2 mmol) of 4-(trifluoromethoxy)phenylhydrazine hydrochloride was dissolved in 22 ml of acetonitrile, 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.5 g (11.3 mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 43.2 hours. The reaction solution was then purified using a column to obtain 0.05 g of a crude product of 1-[4-(trifluoromethoxy)phenyl]-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (R).
[0086] [ka]
[0087] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 345.0 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.42(d,J=10.1Hz,3F),-59.21(s,3H),-120.47(q,J=10.1Hz,1F)
[0088] (Example 19) Preparation of 5-fluoro-3-methoxy-1-(4-methylphenyl)-4-trifluoromethylpyrazole 0.5g (3.2mmol) of p-tolylhydrazine hydrochloride was dissolved in 32ml of acetonitrile, 0.8g (3.8mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.1g (16.4mmol) of N,N-diisopropylethylamine were added and stirred at room temperature for 71.6 hours, and the reaction solution was purified by column to obtain 0.01g (0.04mmol) of 5-fluoro-3-methoxy-1-(4-methylphenyl)-4-trifluoromethylpyrazole represented by the following formula (S). The yield of 5-fluoro-3-methoxy-1-(4-methylphenyl)-4-trifluoromethylpyrazole was 1.3%.
[0089] [ka]
[0090] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 274.9 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.21(d,J=10.1Hz,3F),-120.20(q,J=10.1Hz,1F)
[0091] (Example 20) Preparation of 5-fluoro-1-(2,4-difluorophenyl)-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.8 mmol) of 2,4-difluorophenylhydrazine hydrochloride was dissolved in 28 ml of acetonitrile, and 0.7 g (3.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.8 g (14.1 mmol) of N,N-diisopropylethylamine were added and stirred at room temperature for 67.9 hours. The reaction solution was then purified with a column to obtain 0.03 g of a crude product of 5-fluoro-1-(2,4-difluorophenyl)-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (T).
[0092] [ka]
[0093] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 296.8 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.46 (d,J=10.1Hz,3F),-107.49--107.41(m, 1F),-118.04--117.92(m,1F),-119.55(q,J=10.1Hz,1F)
[0094] Example 21 Preparation of 5-fluoro-1-(pentafluorophenyl)-3-methoxy-4-trifluoromethylpyrazole 0.5g (2.6mmol) of pentafluorophenylhydrazine hydrochloride was dissolved in 25ml of acetonitrile, 0.6g (2.7mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.8g (13.8mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 74.3 hours. The reaction solution was then purified with a column to obtain 0.07g of a crude product of 5-fluoro-1-(pentafluorophenyl)-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (U).
[0095] [ka]
[0096] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 350.1 ([M] - ) 19F-NMR (400MHz, CDCl3) δppm:-58.79 (d,J=10.1Hz,3F),-119.17(tq,J=5.8,10.1Hz,1F),-145.58--145.47(m,2F),-150.52(ddd,J=2.9,2.9,21.7Hz,1F),-160.90--160.75(m,2F)
[0097] Example 22 Preparation of 5-fluoro-1-[4-(trifluoromethyl)phenyl]-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.9 mmol) of 4-(trifluoromethyl)phenylhydrazine hydrochloride was dissolved in 28 ml of acetonitrile, 0.7 g (3.3 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 2.1 g (15.9 mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 64.5 hours. The reaction solution was then purified with a column to obtain 0.07 g of a crude product of 5-fluoro-1-[4-(trifluoromethyl)phenyl]-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (V).
[0098] [ka]
[0099] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 328.8 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.53(d,J=10.1Hz,3F),-63.74(s,3H),-119.30(q,J=10.1Hz,1F)
[0100] (Example 23) Preparation of 1-(2,4,6-trichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.9 mmol) of 2,4,6-trichlorophenylhydrazine hydrochloride was dissolved in 24 ml of acetonitrile, and approximately 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6 g (12.3 mmol) of N,N-diisopropylethylamine were added and stirred at room temperature for 17 days. The reaction solution was then purified using a column to obtain a crude product of 1-(2,4,6-trichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (W).
[0101] [ka]
[0102] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 364.3 ([M+H] + )
[0103] (Example 24) Preparation of 1-(3,4-dichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole 0.5 g (2.4 mmol) of 3,4-dichlorophenylhydrazine hydrochloride was dissolved in 23 ml of acetonitrile, and about 0.6 g (2.8 mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.6 g (12.3 mmol) of N,N-diisopropylethylamine were added and stirred at room temperature for 72 hours. The reaction solution was then purified with a column to obtain 0.04 g of a crude product of 1-(3,4-dichlorophenyl)-5-fluoro-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (X).
[0104] [ka]
[0105] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 330.2 ([M+H] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.56 (d,J=10.1Hz,3F),-119.47(q,J=10.1Hz,1F)
[0106] (Example 25) Preparation of 5-fluoro-1-(4-iodophenyl)-3-methoxy-4-trifluoromethylpyrazole 0.5g (2.2mmol) of 4-iodophenylhydrazine hydrochloride was dissolved in 21ml of acetonitrile, 0.5g (2.4mmol) of 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)-1-propene and 1.5g (11.2mmol) of N,N-diisopropylethylamine were added, and the mixture was stirred at room temperature for 17 days. The reaction solution was then purified using a column to obtain 0.02g of a crude product of 5-fluoro-1-(4-iodophenyl)-3-methoxy-4-trifluoromethylpyrazole represented by the following formula (Y).
[0107] [ka]
[0108] The analytical results of the obtained target substance are as follows: Mass spectrum (APCl, m / z): 386.2 ([M] + ) 19 F-NMR (400MHz, CDCl3) δppm:-58.43 (d,J=10.1Hz,3F),-120.01(q,J=10.1Hz,1F)
Claims
1. A fluorine-containing pyrazole compound represented by the following general formula (1): 【Chemistry 1】 (In the above general formula (1), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent, or a fused ring not containing a heteroatom as a ring atom.)
2. The fluorine-containing pyrazole compound according to claim 1 , wherein the ring Z has 6, 10, 14, 18 or 22 π electrons.
3. A fluorine-containing pyrazole compound according to claim 1 or 2, wherein the substituted phenyl group has at least one substituent selected from the group consisting of a halogen atom, an alkyl group, a nitro group, an alkoxy group, a halogenated alkoxy group, or a sulfonyl group.
4. A fluorine-containing pyrazole compound according to claim 1 or 2, wherein the substituted phenyl group has at least one substituent selected from the group consisting of an alkyl group, a nitro group, an alkoxy group, a halogenated alkoxy group, or a sulfonyl group.
5. A method for producing a fluorine-containing pyrazole compound, comprising a step of reacting a fluoroisobutylene derivative represented by the following general formula (2) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorine-containing pyrazole compound represented by the following general formula (1): 【Chemistry 2】 (In the above general formulas (1) to (3), R represents a hydrocarbon group having 1 to 12 carbon atoms, and ring Z represents a phenyl group having a substituent, or a fused ring that does not contain a heteroatom as a ring atom.
6. A method for producing a fluorine-containing pyrazole compound, comprising a step of reacting a fluoroisobutane derivative represented by the following general formula (4) with a compound represented by the following general formula (3) or a salt thereof to obtain a fluorine-containing pyrazole compound represented by the following general formula (1): 【Chemistry 3】 (In the above general formulas (1), (3) and (4), R represents a hydrocarbon group having 1 to 12 carbon atoms; X is a halogen atom, -OA 1 , -SO m A 1 (m is an integer from 0 to 3), or -NA 1 A 2 represents A 1 , A 2 each independently represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, Ring Z represents a substituted phenyl group or a fused ring that does not contain a heteroatom as a ring atom.
7. The method for producing a fluorine-containing pyrazole compound according to claim 5 or 6, wherein the step of obtaining the fluorine-containing pyrazole compound is carried out in the presence of a fluoride ion scavenger.
8. The method for producing a fluorine-containing pyrazole compound according to any one of claims 5 to 7, wherein the ring Z has 6, 10, 14, 18 or 22 π electrons.
9. A method for producing a fluorine-containing pyrazole compound described in any one of claims 5 to 8, wherein the substituted phenyl group has at least one substituent selected from the group consisting of a halogen atom, an alkyl group, a nitro group, an alkoxy group, a halogenated alkoxy group, or a sulfonyl group.
10. A method for producing a fluorine-containing pyrazole compound described in any one of claims 5 to 8, wherein the substituted phenyl group has at least one substituent selected from the group consisting of an alkyl group, a nitro group, an alkoxy group, a halogenated alkoxy group, or a sulfonyl group.
Citation Information
Patent Citations
Fluorine-containing pyrazole compound, its production and pest control agent
JP1993230029A
Tetrazolinone compounds and its use
JP2015027978A
Method for the preparation of 5-fluoro-1h-pyrazoles
JP2016539945A
Plant disease control method
JP2020079269A
Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
WO2004013131A2
